|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 239/28 | |
| A61K 31/505 | |||
| A61P 31/18 |
| (11) | Number of the document | 3169684 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15822801.5 |
| Date of filing the European patent application | 2015-07-17 | |
| (97) | Date of publication of the European application | 2017-05-24 |
| (45) | Date of publication and mention of the grant of the patent | 2019-06-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/040848 |
| Date | 2015-07-17 |
| (87) | Number | WO 2016/011316 |
| Date | 2016-01-21 |
| (30) | Number | Date | Country code |
| 201462025840 P | 2014-07-17 | US |
| (72) |
DOMINGUEZ, Celia, US
MUŃOZ-SANJUAN, Ignacio, US
TOLEDO-SHERMAN, Leticia, US
|
| (73) |
CHDI Foundation, Inc.,
350 Seventh Ave Suite 200, New York, NY 10001,
US
|
| (54) | COMBINATION OF KMO INHIBITOR 6-(3-CHLORO-4-CYCLOPROPOXYPHENYL)PYRIMIDINE-4-CARBOXYLIC ACID WITH ANTIVIRAL AGENT FOR TREATING HIV RELATED NEUROLOGICAL DISORDERS |
| COMBINATION OF KMO INHIBITOR 6-(3-CHLORO-4-CYCLOPROPOXYPHENYL)PYRIMIDINE-4-CARBOXYLIC ACID WITH ANTIVIRAL AGENT FOR TREATING HIV RELATED NEUROLOGICAL DISORDERS |